| 血脂康对高脂血症患者C反应蛋白的影响 |
| |
| 引用本文： | 苏显明,崔长琮,黄若文,宋海凌,李晓霞.血脂康对高脂血症患者C反应蛋白的影响[J].西安交通大学学报(医学版),2003,24(1):61-62,81. |
| |
| 作者姓名： | 苏显明 崔长琮 黄若文 宋海凌 李晓霞 |
| |
| 作者单位： | 1. 西安交通大学第一医院老年心血管内科,西安,710061
2. 陕西省长途电信线务局卫生所,西安,710004 |
| |
| 摘 要： | 目的 研究血脂康对高脂血症患者C反应蛋白 (CRP)的影响。方法 测定 45例高脂血症患者应用血脂康治疗前后血脂、CRP水平的变化。结果 经过 8周血脂康治疗 ,总胆固醇、LDL C、TG及CRP分别下降2 8.13 % (P <0 .0 1)、2 1.92 % (P <0 .0 1)、13 .3 7% (P <0 .0 5 )及 13 .75 % (P <0 .0 5 ) ,而HDL C升高 9.2 5 %(P >0 .0 5 )。结论 血脂康不仅可调脂 ,也可以降低CRP水平
|
| 关 键 词： | 血脂康 羟甲基戊二酸单酰辅酶A还原酶抑制剂 高脂血症 C反应蛋白 |
| 文章编号： | 1671-8259(2003)01-0061-02 |
Effect of Xuezhikang therapy on C-reactive protein level of hyperlipidemia patients |
| |
| Su Xianming,Cui Changcong,Huang Ruowen,Song Hailing,Li Xiaoxia.Effect of Xuezhikang therapy on C-reactive protein level of hyperlipidemia patients[J].Journal of Xi‘an Jiaotong University:Medical Sciences,2003,24(1):61-62,81. |
| |
| Authors: | Su Xianming Cui Changcong Huang Ruowen Song Hailing Li Xiaoxia |
| |
| Abstract: | Objective To study the effect of Xuezhikang therapy on C-reactive protein level of hyperlipidemia patients. Methods Blood samples from 45 patients with hyperlipidemia before and after 8-week Xuezhikang therapy were tested for C-reactive protein(CRP) and lipid/lipoprotient levels and statistical analyses. Results After 8-week Xuezhikang therapy, the levels of total-cholesterol, low-density lipoprotient cholesterol(LDL-C), triglycerides(TG) and CRP decreased by 28.13% (P<0.01), 21.92% (P<0.01), 13.37% (P<0.05) and 13.75% (P<0.05) compared with those before the therapy; high-density lipoprotient cholesterol(HDL-C) elevated by 9.25%(P>0.05). Conclusion Xuezhikang can reduce lipid/lipoprotient and CRP levels. |
| |
| Keywords: | Xuezhikang hydroxymethylglutaryl coenzyme A reductase inhibitor hyperlipidemia C-reactive protein |
| 本文献已被 CNKI 万方数据 等数据库收录！ |
|
